Chinese Journal of Antituberculosis ›› 2018, Vol. 40 ›› Issue (12): 1330-1334.doi: 10.3969/j.issn.1000-6621.2018.12.017
• Original Articles • Previous Articles Next Articles
LIN Shu-fang(),WEI Shu-zhen,ZHAO Yong,LIN Jian,LIN Yong-ming.
Received:
2018-07-26
Online:
2018-12-10
Published:
2018-12-10
LIN Shu-fang,WEI Shu-zhen,ZHAO Yong,LIN Jian,LIN Yong-ming.. Phenotypic pyrazinamide resistance and genotypic characteristics among multidrug-resistant Mycobacterium tuberculosis isolates in Fujian Province[J]. Chinese Journal of Antituberculosis, 2018, 40(12): 1330-1334. doi: 10.3969/j.issn.1000-6621.2018.12.017
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.3969/j.issn.1000-6621.2018.12.017
[1] |
Ibrahim M, Andries K, Lounis N , et al. Synergistic activity of R207910 combined with pyrazinamide against murine tuberculosis. Antimicrob Agents Chemother, 2007,51(3):1011-1015.
doi: 10.1128/AAC.00898-06 URL pmid: 17178794 |
[2] |
Tasneen R, Tyagi S, Williams K , et al. Enhanced bactericidal activity of rifampin and/or pyrazinamide when combined with PA-824 in a murine model of tuberculosis. Antimicrob Agents Chemother, 2008,52(10):3664-3668.
doi: 10.1016/S0167-8655(00)00032-5 URL pmid: 18694943 |
[3] |
Diacon AH, Donald PR, Pym A , et al. Randomized pilot trial of eight weeks of bedaquiline (TMC207) treatment for multidrug-resistant tuberculosis: long-term outcome, tolerability, and effect on emergence of drug resistance. Antimicrob Agents Chemother, 2012,56(6):3271-3276.
doi: 10.1128/AAC.06126-11 URL pmid: 22391540 |
[4] |
Whitfield MG, Soeters HM, Warren RM , et al. A global perspective on pyrazinamide resistance: systematic review and meta-analysis. PLoS One, 2015,10(7):e0133869.
doi: 10.1371/journal.pone.0133869 URL pmid: 4517823 |
[5] |
Kam KM, Yip CW, Tse LW , et al. Utility of mycobacterial interspersed repetitive unit typing for differentiating multidrug-resistant Mycobacterium tuberculosis isolates of the Beijing family. J Clin Microbiol, 2005,43(1):306-313.
doi: 10.1128/JCM.43.1.306-313.2005 URL pmid: 15634987 |
[6] | Lillebaek T, Andersen AB, Dirksen A , et al. Mycobacterium tuberculosis Beijing genotype. Emerg Infect Dis, 2003,9(12):1553-1557. |
[7] | Glynn JR, Whiteley J, Bifani PJ , et al. Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic review. Emerg Infect Dis, 2002,8(8):843-849. |
[8] | Gori A, Bandera A, Marchetti G , et al. Spoligotyping and Mycobacterium tuberculosis. Emerg Infect Dis, 2005,11(8):1242-1248. |
[9] | World Health Organization , International Union Against Tuberculosis and Lung Diseases. Guidelines for surveillance of drug resistance in tuberculosis. Geneva: World Health Organi-zation, 1997. |
[10] |
World Health Organization . Policy guidance on drug susceptibility testing (DST) of second line antituberculosis drug. Geneva: World Health Organization, 2008: 11.
URL pmid: 26290924 |
[11] |
Viana-Niero C, Gutierrez C, Sola C , et al. Genetic diversity of Mycobacterium africanum clinical isolates based on IS6110-restriction fragment length polymorphiSm analysis, spoligotyping, and variable number of tandem DNA repeats. J Clin Microbiol, 2001,39(1):57-65.
doi: 10.1128/JCM.39.1.57-65.2001 URL pmid: 87680 |
[12] |
Brudey K, Driscoll JR, Rigouts L , et al. Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology. BMC Microbiol, 2006,6:23.
doi: 10.1186/1471-2180-6-23 URL pmid: 1468417 |
[13] | Weniger T, Krawczyk J, Supply P , et al. MIRU-VNTRplus: a web tool for polyphasic genotyping of Mycobacterium tuberculosis complex bacteria. Nucleic Acids Res, 2010,38(Web Server issue):W326-W331. |
[14] | Xu P, Wu J, Yang C , et al. Prevalence and transmission of pyrazinamide resistant Mycobacterium tuberculosis in China. Tuberculosis (Edinb), 2016,98:56-61. |
[15] |
Kurbatova EV, Cavanaugh JS, Dalton T , et al. Epidemiology of pyrazinamide-resistant tuberculosis in the United States, 1999—2009. Clin Infect Dis, 2013,57(8):1081-1093.
doi: 10.1093/cid/cit452 URL pmid: 4578633 |
[16] |
Gu Y, Yu X, Jiang G , et al. Pyrazinamide resistance among multidrug-resistant tuberculosis clinical isolates in a national referral center of China and its correlations with pncA, rpsA, and panD gene mutations. Diagn Microbiol Infect Dis, 2016,84(3):207-211.
doi: 10.1016/j.diagmicrobio.2015.10.017 URL pmid: 26775806 |
[17] |
Pang Y, Zhu D, Zheng H , et al. Prevalence and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Southern China. BMC Infect Dis, 2017,17(1):711.
doi: 10.1186/s12879-017-2761-6 URL pmid: 29110640 |
[18] | Alame-Emane AK, Xu P, Pierre-Audigier C , et al. Pyrazinamide resistance in Mycobacterium tuberculosis arises after rifa-mpicin and fluoroquinolone resistance. Int J Tuberc Lung Dis, 2015,19(6):679-684. |
[19] | 周银发, 张山鹰, 魏淑贞 , 等. 福建省耐多药结核分枝杆菌对吡嗪酰胺耐药性的研究. 结核病与肺部健康杂志, 2018,7(2):123-127. |
[20] |
梁庆福, 郑金凤, 陈求扬 , 等. 218例涂阳肺结核吡嗪酰胺耐药情况分析. 中国人兽共患病学报, 2012,28(10):1000-1002.
doi: 10.3969/cjz.j.issn.1002-2694.2012.10.008 URL |
[21] | Han SJ, Song T, Cho YJ , et al. Complete genome sequence of Mycobacterium tuberculosis K from a Korean high school outbreak, belonging to the Beijing family. Stand Genomic Sci, 2015,10:78. |
[22] | Maeda S, Wada T, Iwamoto T , et al. Beijing family Mycobacterium tuberculosis isolated from throughout Japan: phylogeny and genetic features. Int J Tuberc Lung Dis, 2010,14(9):1201-1204. |
[23] |
刘飞鹰, 刘志广, 王喜文 , 等. Spoligotyping对广西地区208株结核分枝杆菌临床分离株的基因分型. 中国人兽共患病学报, 2007,23(12):1226-1230.
doi: 10.3969/j.issn.1002-2694.2007.12.015 URL |
[24] |
王晓萌, 吕冰, 柳正卫 , 等. Spoligotyping和MLVA用于71株浙江省结核分枝杆菌临床分离株基因分型的初步研究. 中国人兽共患病学报, 2008,24(12):1090-1094.
doi: 10.3969/j.issn.1002-2694.2008.12.002 URL |
[25] | Li Y, Cao X, Li S , et al. Characterization of Mycobacterium tuberculosis isolates from Hebei, China: genotypes and drug susceptibility phenotypes. BMC Infect Dis, 2016,16:107. |
[26] |
逄宇, 夏辉, 姜广路 , 等. 中国结核分枝杆菌寡核苷酸基因分型及其耐药性分析. 中华检验医学杂志, 2011,34(11):1023-1028.
doi: 10.3760/cma.j.issn.1009-9158.2011.11.014 URL |
[27] |
王胜芬, 赵雁林, 黄海荣 , 等. 结核分枝杆菌北京基因型菌株与耐药表型的关系. 中国医学科学院学报, 2009,31(4):427-431.
doi: 10.3881/j.issn.1000-503X.2009.04.009 URL |
[1] | Tuberculosis Control Branch of Chinese Antituberculosis Association, The Youth Branch of Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis. Evidence-based guidelines for application of digital adherence technology in tuberculosis medication management in China [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 385-397. |
[2] | Li Jinhao, Hu Dongmei, Xu Caihong. Investigation on the willingness of tuberculosis health-care workers to implement tuberculosis preventive treatment and analysis of influencing factors [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 398-407. |
[3] | Li Yuhong, Mei Jinzhou, Su Wei, Ruan Yunzhou, Liu Yushu, Zhao Yanlin, Liu Xiaoqiu. Analysis of the treatment outcomes and influencing factors of rifampicin-resistant pulmonary tuberculosis patients aged 65 and above in China from 2015 to 2021 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 408-415. |
[4] | Jiang Xue, Bai Yunlong, Ma Jianjun, An Yuan, Yang Fan, Zhao Qinglong. Status and influencing factors of diagnosis and treatment delay of rifampicin resistant pulmonary tuberculosis patients, Jilin Province, 2020—2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 416-424. |
[5] | Wu Xuan, Zhang Yanqiu, Xu Jiying, Meng Dan, Sun Dingyong. Analysis of factors influencing the treatment outcomes of patients with pulmonary tuberculosis and diabetes mellitus in Henan Province (2019—2023) [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 425-431. |
[6] | An Yuan, Bai Yunlong, Zhao Qinglong, Ma Jianjun, Jiang Xue, Pan Yan, Gao Ying, Gao Zhihui. Analysis of treatment outcomes and influencing factors of patients with pulmonary tuberculosis complicated with diabetes mellitus in Jilin Province,2018—2022 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 432-438. |
[7] | Feng Wei, Zheng Hailun, Meng Weili, Luo Ping. Analysis of under-reporting before arrival of pulmonary tuberculosis patients registered and managed by Tuberculosis Prevention and Control Institutions in Xicheng District, Beijing from 2018 to 2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 439-443. |
[8] | Hu Yifan, Du Boping, Wu Yadong, Zhu Chuanzhi, Zhang Lanyue, Jia Hongyan, Sun Qi, Pan Liping, Zhang Zongde, Li Zihui. Experimental study on the role of Mce4C in the uptake and utilization of cholesterol by Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 444-453. |
[9] | Sheng Jie, Hong Kaifeng, Mierzhati Aisha, Tang Wei, Dilixiati Abulizi. Study on the mechanism of IL-22 and p38 MAPK signaling pathways in inhibiting bone destruction in bone and joint tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 454-459. |
[10] | Wang Yingchao, Liu Weiyi, Ji Xiuxiu, Shang Xuetian, Jia Hongyan, Zhang Lanyue, Sun Qi, Du Boping, Zhu Chuanzhi, Pan Liping, Zhang Zongde. Profile analysis of circRNA expression and identification of diagnostic markers in peripheral blood mononuclear cells of tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 460-470. |
[11] | Zhu Mingzhi, Shao Yanqin, Fan Dapeng, Liu Libin, Mei Bin, Dai Lingshan, Cai Long. Diagnostic value of urine lipoarabinomannan antigen detection in extrapulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 471-476. |
[12] | Hao Mingxiao, Mi Jie, Xu Zongyi. Effectiveness of a continuity of care model in patients with tuberculous meningitis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 477-481. |
[13] | Shang Xiyu, Zhang Huifang, Cao Yuqing, Xiong Yibai, Ji Xinyu, Tian Yaxin, Li Jiajia, Wang Ni, Ma Yan. Bibliometric analysis of global research status and hotspots in the basic research of Traditional Chinese Medicine for tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 482-497. |
[14] | Qin Lili, Yang Chengqing, Mai Hongzhen, Xu Qifeng, Xue Xinying, Lu Xiwei. Advances in the clinical diagnosis and treatment of post-tuberculosis chronic pulmonary aspergillosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 498-504. |
[15] | Luo Li, Luo Linzi, Yin Quhua, Zhou Lei, Lu Zhibin, Ding Yan, Xiao Yangbao. Progress in bronchoscopic diagnosis and treatment of lymph node fistula tracheobronchial tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 505-512. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||